Prof. Mirza Naqi Zafar, Pakistan Oral
HLA-driven immunosuppression in living-related kidney transplantation. A protocol for low-income countries

Dr. Cansu Erel Gezegen, Turkey Oral
Outcomes of mTOR Inhibitors Switch for Cutaneous and/or Anogenital Warts Among Kidney Transplant Recipients

Dr. Katharina A Mayer, Austria Oral
Randomized phase 2 trial of felzartamab in humoral transplant rejection

Dr. Audrey Brown, United States Oral
CCR5 Blockade: A novel, safe, and efficacious addition to the immunosuppressive armamentarium following kidney transplantation

Camille N. Kotton, United States Mini-Oral
Quantiferon®-monitor as a biomarker of immunosuppression and predictor of infection: A scoping review

Mr. Rens Kraaijeveld, Netherlands Mini-Oral
Targeting BCL6-mediated responses to inhibit allogeneic T follicular helper cell functions

Prof. Caner Süsal, Turkey Mini-Oral
Tacrolimus metabolism and kidney transplant outcomes

Dr. Kosuke Ono, Japan Mini-Oral
Polymorphisms in molecules regulating follicular helper T cell differentiation predict de novo donor specific antibody formation after liver transplantation

Dr. Sho Takemoto, United States Mini-Oral
Delayed Immune Tolerance for Cardiac Allografts in Nonhuman Primates by Targeting CD154, CD2, and CD28 Costimulation Pathways

Miss Chia-Jung Ke, Taiwan Mini-Oral
Enhancing immunosuppressive medication adherence through a personal optimized system -- Right time and Right dose mobile application